Trevi Therapeutics, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021
Profitability
EBT Margin 11,878.74%7,187.72%2,825.37%
EBIT Margin 10,579.31%7,124.78%2,701.83%
EBITDA Margin 10,579.31%7,124.78%2,701.83%
Operating Margin 10,579.31%7,124.78%2,701.83%
Net Margin 14,699.43%7,183.77%2,823.63%
FCF Margin 10,601.72%6,366.67%2,408.15%
Leverage & Solvency
Interest Coverage Ratio -105.79-71.25-27.02
Times Interest Earned -105.79-71.25-27.02
Valuation
Enterprise Value 66.88M44.48M20.22M
Market Capitalization 66.88M44.48M20.22M
Return Ratios
Return on Sales 118.07%71.84%28.24%